Which ETFs hold R+G PHARMASTUDIES CO LTD A?
301333 is held by 1 of the 504 ETFs we cover. The heaviest allocation is SPEM at 0.0%. The median weight across all funds holding it is 0.0%.
- Covered ETFs Holding It
- 1
- Heaviest Allocation
- 0.00%in SPEM
- Median Weight
- 0.00%across funds that hold it
Funds Holding 301333(1)
| ETF | |||||||
|---|---|---|---|---|---|---|---|
| SPEMState Street® SPDR® Portfolio Emerging Markets ETF | 0.00% | 0.07% | $17.4B | 2.48% | +13.1% | +22.8% | +7.2% |
Expense = net expense ratio from the fund's latest SEC prospectus filing. YTD/1Y/5Y are trailing total returns including dividends (5Y annualized, as of 2026-08-07). Past performance does not predict future results. Sort by any column.
Frequently Asked Questions
Which ETF has the most 301333 exposure?
SPEM has the heaviest 301333 allocation of the ETFs we cover, at 0.00% of its portfolio, based on the fund's latest SEC-reported holdings.
How many ETFs hold 301333?
1 of the 504 ETFs we cover hold R+G PHARMASTUDIES CO LTD A (301333). The median weight across those funds is 0.00%.
What is the cheapest ETF that holds 301333?
SPEM has the lowest expense ratio among covered ETFs holding 301333, at 0.07% per year.
What is the largest ETF that holds 301333?
SPEM (State Street® SPDR® Portfolio Emerging Markets ETF) is the largest covered ETF holding 301333, with $17.4B in assets and a 0.00% position.
Keep Exploring
Look up another stock or compare two of these ETFs to see how much they overlap beyond 301333.